132 GENES FOUND

Show / hide columns »

XML | RDF | TAB | « prev | Page of 3 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KCNH8Potassium channel, voltage gated eag related subfamily H, member 8Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNJ1Potassium channel, inwardly rectifying subfamily J, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ10Potassium channel, inwardly rectifying subfamily J, member 10Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
KCNJ11Potassium channel, inwardly rectifying subfamily J, member 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNJ12Potassium channel, inwardly rectifying subfamily J, member 12FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Golgi apparatus
Cytosol
Group enriched
KCNJ13Potassium channel, inwardly rectifying subfamily J, member 13Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ14Potassium channel, inwardly rectifying subfamily J, member 14Predicted membrane proteins
Voltage-gated ion channels
NucleoliMixed
KCNJ15Potassium channel, inwardly rectifying subfamily J, member 15Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Vesicles
Plasma membrane
Cytosol
Tissue enhanced
KCNJ16Potassium channel, inwardly rectifying subfamily J, member 16Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesGroup enriched
KCNJ2Potassium channel, inwardly rectifying subfamily J, member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ3Potassium channel, inwardly rectifying subfamily J, member 3Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ4Potassium channel, inwardly rectifying subfamily J, member 4Predicted membrane proteins
Voltage-gated ion channels
Group enriched
KCNJ5Potassium channel, inwardly rectifying subfamily J, member 5Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ6Potassium channel, inwardly rectifying subfamily J, member 6Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ8Potassium channel, inwardly rectifying subfamily J, member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNJ9Potassium channel, inwardly rectifying subfamily J, member 9Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNK1Potassium channel, two pore domain subfamily K, member 1Predicted membrane proteins
Voltage-gated ion channels
VesiclesMixed
KCNK12Potassium channel, two pore domain subfamily K, member 12Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNK13Potassium channel, two pore domain subfamily K, member 13Predicted membrane proteins
Voltage-gated ion channels
Nuclear speckles
Cell Junctions
Tissue enhanced
KCNK15Potassium channel, two pore domain subfamily K, member 15Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK16Potassium channel, two pore domain subfamily K, member 16Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK17Potassium channel, two pore domain subfamily K, member 17Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK18Potassium channel, two pore domain subfamily K, member 18Disease related genes
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNK2Potassium channel, two pore domain subfamily K, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Mitochondria
Cytosol
Tissue enhanced
KCNK3Potassium channel, two pore domain subfamily K, member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK4Potassium channel, two pore domain subfamily K, member 4Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNK5Potassium channel, two pore domain subfamily K, member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
NucleusTissue enhanced
KCNK6Potassium channel, two pore domain subfamily K, member 6Predicted membrane proteins
Transporters
Voltage-gated ion channels
Plasma membrane
Actin filaments
Cytosol
Mixed
KCNK7Potassium channel, two pore domain subfamily K, member 7Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Voltage-gated ion channels
Plasma membraneTissue enriched
KCNK9Potassium channel, two pore domain subfamily K, member 9Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNMA1Potassium channel, calcium activated large conductance subfamily M alpha, member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNN1Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 1Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Actin filaments
Cytosol
Tissue enriched
KCNN2Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Cytosol
Tissue enhanced
KCNN3Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3Predicted membrane proteins
Voltage-gated ion channels
NucleoplasmTissue enhanced
KCNN4Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium channel, voltage gated KQT-like subfamily Q, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium channel, voltage gated KQT-like subfamily Q, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumTissue enriched
KCNQ3Potassium channel, voltage gated KQT-like subfamily Q, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNQ4Potassium channel, voltage gated KQT-like subfamily Q, member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNQ5Potassium channel, voltage gated KQT-like subfamily Q, member 5Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
VesiclesTissue enhanced
KCNS1Potassium voltage-gated channel, modifier subfamily S, member 1Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNS2Potassium voltage-gated channel, modifier subfamily S, member 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNS3Potassium voltage-gated channel, modifier subfamily S, member 3Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Golgi apparatus
Plasma membrane
Cytosol
Tissue enhanced
KCNT1Potassium channel, sodium activated subfamily T, member 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNT2Potassium channel, sodium activated subfamily T, member 2Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesTissue enhanced
KCNV1Potassium channel, voltage gated modifier subfamily V, member 1Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNV2Potassium channel, voltage gated modifier subfamily V, member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
MCOLN1Mucolipin 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Plasma membrane
Cytosol
Expressed in all
MCOLN2Mucolipin 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Intermediate filamentsMixed
MCOLN3Mucolipin 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoli
Cytosol
Tissue enhanced

« prev | Page of 3 | next »